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Purpose: To assess the efficacy of balloon angioplasty inthe superficial femoral artery (SFA) 
and popliteal artery for relief of lower-limb claudication and critical ischemia. 
Methods: All patients who underwent SFA or popliteal balloon angioplasty at the Royal 
Adelaide Hospital between January 1989 and September 1994 were reviewed. Risk factors, 
indications, angiographic variables, and complications were assessed. Outcome was 
expressed in life-table form as patency, limb survival, and patient survival rates. 
Results: One hundred seventy-six patients (96 men, 80 women) who underwent 200 
balloon angioplasty procedures were monitored for a mean of 25 months. Seventy-four 
percent of procedures were for claudication relief and 26% for critical ischemia. The 
cumulative patency rate at 24 months for all cases was 46%. The limb salvage rate was 95%, 
and the patient survival rate was 91% at 24 months. 
Conclusion: Percutaneous transluminal ngioplasty of the SFA and popliteal arteries is 
commonly used to treat claudication and critical ischemia but is associated with a high 
initial failure rate and poor patency at 24 months. Balloon angioplasty is not recommended 
to treat claudication. (J VASC SURG 1996;23:679-85.) 
Pcrcutaneous transluminal angioplasty (PTA) is 
often considered as an initial treatment for leg isch- 
emia if an appropriate l sion is identified on angiogra- 
phy. The likelihood of success from PTA in the short 
and long term is often not considered because of its 
appeal as a minimally invasive technique. The aim of 
this study was to assess the efficacy of balloon angio- 
plasty in the superficial femoral artery (SFA) and 
popliteal artery for both critical ischemia nd claudi- 
cation9 
METHODS 
All patients who had balloon angioplasty of the 
SFA or poplitcal artery at the Royal Adelaide Hos- 
pital between January 1989 and September 1994 
wcrc identified and included in the study on an 
intention-to-treat basis. These included cases in 
which thrombolytic therapy was performed with 
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balloon angioplasty. Cases in which atherectomy, 
laser angioplasty, or stcnt insertion were performed 
were excluded. 
All angioplasties were performed through an an- 
tegrade puncture of the common femoral artery, after 
which a straight guide wire (Radio focus; Terumo; 
Tokyo, Japan) was passed into the SFA. A 6F sheath 
(Check flow; W.A Cook; Brisbane, Australia) was then 
passed over the wire, and 3000 IU heparin was 
administered. 
Once the guide wire was advanced across the 
lesion, a 4-cm • 5- to 6-mm diameter balloon (Ac- 
cent, W.A. Cook) was placed across the lesion and 
inflated until the unconstrained contour of the bal- 
loon was obtained. Inflation was maintained for 30 
seconds and repeated three times. Postangioplasty 
images were obtained, and thrombolytic therapy or 
anticoagulation was used only if thrombotic or em- 
bolic complications were evident. 
Patients were observed in the hospital after the 
procedure. The puncture site was inspected before 
discharge and the ankle-brachial rtery pressure index 
(ABI) was measured within 24 hours of  angioplasty 
and compared with the preprocedural value. Patients 
were discharged and given 325 mg aspirin per day, and 
were evaluated in the outpatient department a 1 -, 3-, 
679 
JOURNAL OF VASCULAR SURGERY 
680 Stanley et al. April 1996 
Table I. Patient data (n = 200) Table IV.  Angiographic findings (n = 200) 
Men 96 (55%) Stenoses 119 (59%) 
Women 80 (45%) Single 76 
Claudication 148 (74%) Multiple 42 
Criticalischemia 52 (26%) Occlusion 81 (41%) 
Cardiac disease 86 (44%) Short <5 cm 63 
Hypertension 90 (45%) Long >5 cm 18 
Current smokers 63 (31%) Good runoff 138 (69%) 
Ex-smokers 71 (36%) Poor runoff 62 (31%) 
Diabetes 62 (31%) Proximal SFA 14 (7%) 
Middle SFA 56 (28%) 
Distal SFA 97 (48%) 
Popliteal 33 (16%) 
Table I I .  Primary intervention after 
angioplasty (n = 59) 
Fcmorodistal graft 41 
Angioplasty 9 
Amputation 7 
Chemical sympathectomy 1 
Endarterectomy 1 
Table I I I .  Patients undergoing further 
interventions (n = 59) 
Claudication 39 (66%) 
Critical ischemia 20 (26%) 
Stenoses 31 (53%) 
Single 19 (32%) 
Multiple 12 (20%) 
Occlusions 28 (47%) 
Short 17 (29%) 
Long 11 (19%) 
Good runoff 32 (54%) 
Poor runoff 27 (46%) 
and 6-month periods and thereafter at intervals of  6 
months. The ABI was recorded at each visit. I f  
clinically warranted, duplex ultrasound or arteriogra- 
phy were used to determine reocclusion or delineate 
the cause o fa  fhlling ABI or return of  symptoms. 
Patient details, risk factors, indications, complica- 
tions, and pre- and postangioplasty ABI scores were 
retrospectively obtained from patient notes and re- 
corded on a database system. All patients had ABIs 
performed before angioplasty. The presence of  car- 
diac disease, hypertension, smoking, and diabetes was 
recorded. Indications were assessed as either intermit- 
tent claudication alone or critical ischemia with rest 
pain, ulcers, or gangrene. All complications resulting 
fi'om the angiography were recorded. Technical fhil- 
ures were not included as complications but were 
recorded as tkilure o f  patency. I f  the patient had not 
reached an cndpoint o f  further vascular intervention 
(including reangioplasty), amputation, or death and 
had not been reviewed in the previous 4 months, he or 
she was recalled for reassessment. 
Table V. Major complications (n = 12) 
Hematoma 1 
Hemorrhage 2 
Thrombosis 5 
False aneurysm 2 
Disruption artery 1 
Arteriovenous fistula 1 
Table VI .  Minor complications (n = 39) 
Hematoma 32 
Distal embolization 5 
Groin lymphocele 1 
Vasculitis 1 
Angioplasty films were retrospectively obtained 
and were read by a dedicated observer (BS) who was 
blinded to the outcome of  the procedure. Lesions 
were classified as either stenoses or occlusions, single 
or multiple, and less than or greater than 5 cm long. 
The anatomic site o f  the lesion and the number of  
patent distal runoffvessels from the popliteal artery to 
the ankle were also assessed. Good runoffwas defined 
as two or three runoffvessels patent o the ankle; poor 
runoffwas defined as one or no runoffvessels. 
Angioplasty was considered successful when there 
was a sustained rise o f  postangioplasty ABI o f  >0.1 
from the preangioplasty ABI 3. These arteries were 
said to be patent. Initial success was defined as success 
immediately after angioplasty. Early success was de- 
fined as a patent artery at 1 month and late success as 
a patent artery at 24 months. 
Failure occurred if the ABI declined or the rise was 
<0.1 or if the stenosis or occlusion was shown to have 
recurred with duplex ultrasound or arteriography. 
Initial failure was defined as failure occurring at the 
time of  angioplasty. Subsequent failure was said to 
occur if the ABI fell below a level of  0.1 greater than 
the preangioplastv ABI, if a further vascular interven- 
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Fig. 1. Cumulative patency rates fbr all angioplasties performed over 5-year period. Primary 
patency was 58% (SE, 4.0) at 1 ),ear, 46% (SE, 4.7) at 2 years, 38% (SE, 5.8) at 3 years, 30% (SE, 
6.8) at 4 years, and 26% (SE, 8.3) at 5 years. 
Table VI I .  Comparison of primary patency rates at 1 and 24 months tbr variables with 
significant difference 
Percentage patent 
1 month 24 months 
Claudication 75 (SE 3.6) 49 (SE 5.4) 
Critical ischaemia 54 (SE 6.9) 39 (SE 9.6) 
Occlusioqs hort (<5 cm) 73 (SE 5.7) 57 (SE 7.8) 
long (>5cm) 33 (SE 11.1) 21 (SE 10.7) 
Good run-off(2 or 3 vessels) 76 (SE 3.7) 55 (SE 5.6)* 
Poor run-off(0 or 1 vessels) 55 (SE 6.3) 23 (SE 7.2)* 
*Significant on multivariate analysis (p < 0.05). 
The variables undergoing comparison that showed significance using tmivariatc analysis arc claudication versus critical ischemia, short versus 
long occlusions, and good versns poor run-off. 
tion was necessary to relieve ischemia, or if amputa- 
tion of the limb was performed. These arteries were 
said to have occluded. Early failure was defined as 
failure within 1 month. Patients whose arteries had 
occluded were observed with respect to further inter- 
ventions, reconstruction, or amputations. All patient 
deaths were recorded. 
Kaplan-Meier 4 life-table analysis was used to assess 
patency, limb survival, and patient survival rates for 
femoropopliteal balloon angioplasty for all variables. 
Log rank univariate analysis s was performed to com- 
pare life tables, limb salvage, or patient mortality rates 
for any given variable. Cox regression multivariate 
analysis was performed for those variables where 
p < 0.25 on univariate analysis to identify indepen- 
dent predictors of  success. Significance levels were set 
at p < 0.05. 
RESULTS 
Subjects. Between January 1989 and September 
1994, 215 SFA or popliteal artery balloon angioplas- 
ties were perfbrmed in 189 patients. Of  these, fol- 
low-up data and arteriograms were available for 176 
patients who underwent 200 angioplasty procedures. 
Thus data was available for 93% of all PTAs performed 
within the specified time period. The median age of 
patients at the time ofangioplasty was 69 years (range, 
38 to 93 years). Median follow-up was 25 months 
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Fig. 2. Cumulative limb survival rates for all angioplasties. 
(range, 0 to 72 months). Patient characteristics are 
shown in Table I. 
Fifty-nine angioplastied limbs (29%) underwent a 
subsequent further interventional procedure as 
shown in Tables II and III. Four additional patients 
had amputation as a second surgical procedure. Arte- 
riographic findings are summarized in Table IV. 
Initial success. The technical success rate was 
93%. Failures resulted from inability to cross occlu- 
sions (seven) and tight stenoses (two), inability to 
inflate the balloon (two), and inability to enter the 
patent distal umen (five). In three patients there was 
a combination of these factors. One angioplasty was 
not completed because of major changes in angio- 
graphic appearance at the time of angioplasty when 
compared with an earlier arteriogram, making it 
unsuitable for angioplasty. Median ABI increased 
from 0.63 (0.0 to 1.16) to 0.85 (0.0 to 1.21) 
immediately after angioplasty. There were 13 techni- 
cal failures and another 41 failures within 24 hours, 
giving an initial success rate of 73%. Short occlusions 
had an initial success of 73% compared with 39% for 
long occlusions (p _< 0.05). In the presence of a good 
runoff, the initial success was 79%, whereas for poor 
runoff success was 60% (p _< 0.01). 
Complications. Complications ofangioplasty are 
shown in Tables V and VI. Fifty-one complications 
(25%) occurred in 45 procedures. Most groin he- 
matomas and hemorrhages were minor. Two groin 
hemorrhages required a surgical repair. One he- 
matoma required transfusion. Complications were 
associated with an initial failure in 14 cases. 
Patency. Cumulative patency for all angioplasty is 
shown in Fig. 1. For all angioplasties, the early success 
rate at 1 month was 69% (SE, 3.3) with late success 
rates of 58% (SE, 4.0) at 1 year, 46% (SE, 4.7) at 2 
years, 38% (SE, 5.8) at 3 years, 30% (SE, 6.8) at 4 
years, and 26% (SE, 8.3) at 5 years. 
One-month and 24-month patency rates for vari- 
ables shown to be significant on univariate analysis are 
shown in Table VII. After multivariate analysis, only 
runoff was shown to be an independent predictor of 
success (p < 0.005). The risk ratio score was 1.8 (1.2 
to 2.6). Indication was not an independent predictor 
of success (p = 0.15). 
Limb survival. Ten amputations were performed 
within 6 months ofangioplasty; one further amputa- 
tion was performed 63 months after angioplasty. All 
early amputations (<6 months) were in cases of critical 
ischemia with poor runofI: One claudicant with good 
runoff underwent amputation at 63 months. The 
limb survival rate (Fig. 2) for all angioplasties was 98% 
(SE 1.01) at 1 month and 95% (SE 2.03) at 24 
months. Independent predictors of limb survival were 
claudication versus critical ischemia (p < 0.05) and 
good versus poor runoff (p < 0.005). 
Patient survival. The patient survival rate for all 
angioplasties i  shown in Fig. 3. Four patients (2%) 
died within 30 days of operation--two in the hospital, 
one from causes unrelated to the angioplasty, and one 
from acute renal failure and pulmonary edema, most 
likely from the angiogram. The patient survival rate 
was 91% (SE 2.49) at 2 years and 84% (SE 4.71) at 4 
years. Independent predictors of patient survival were 
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indication (p < 0.001 ) and runoff(p < 0.05). Patient 
survival at 2 years for patients with claudication was 
96% (SE, 1.9) compared with 76% (SE, 7.8) for 
patients with critical ischemia (p < 0.05). 
D ISCUSSION 
Minimally invasive therapy is considered to bc 
quite effective because it allows intervention com- 
bined with short-term hospital admission. PTA for 
SFA and poplitcal lesions may be prefkrable to bypass 
surgery because of its potential benefit, easy applica- 
tion, and low morbidity rate. Our results of 69% and 
46% patency at 1 and 24 months, respectively, are 
similar to other reports of femoral and poplitcal 
angioplasties with 2-year patcncy rates ranging from 
41% to 59%. 6-1~ It must be remembered, however, 
that we obtained a 93% follow-up; if complete fol- 
low-up had been obtained, the above results might 
have been slightly altered. Seventy-four percent of our 
PTAs were performed for claudication i  which cxcr- 
cise alone may produce abetter outcome and has the 
added benefit of treating ipsilateral and contralateral 
lesions, l ~ With 2-year patency rates of 46% overall, an 
attempt was made to determine if there was a sub- 
group of patients who benefited or did poorly fi~om 
PTA. The arterial patency rate was a better discrimi- 
nator than the limb salvage rate, which was 98% at 1 
month and 95% at 24 months. 
The technical success rate at angioplasty of 93% 
compares well with the success of 90% 6 and 91% 12 for 
other reported studies. Our initial success rate of 73% 
represents a possible 20% failure within 24 hours. An 
early patency rate of 69% indicates that the majority of 
angioplasties that failed early did so in the first 24 
hours. 
The 20% of technically successful angioplasties 
that f~tiled to increase the ABI at 24 hours may 
represent an occlusion of the dilated lesion or may 
indicate that the dilated lesion was not the major 
contributor to hemodynamic compromise. However, 
this question cannot be answered in this retrospective 
review. In a prospective study this question could be 
easily answered by either duplex ultrasound or even 
repeat angiogram by a 21-gauge needle in patients 
whose ABI failed to rise. 
Claudication was associated with better patency 
outcomes (p < 0.05) when compared with critical 
ischernia, as were short occlusions compared with 
long occlusions. Good runoff was an independent 
predictor of better patency outcomes compared with 
poor runoff. Claudication and critical ischemia re the 
clinical indications for intervention; the other signifi- 
cant predictors ofpatency are radiologic findings. It is 
important in the clinical setting to focus on the 
symptoms and overall patency in relation to these 
indications; if they do not warrant intervention, an 
angiogram that will delineate the other significant 
variables hould not be perfbrmed. 
Despite a significant difference in the above vari- 
ables, the 2-year patency rate for claudication was only 
49%. This finding is clinically relevant because it is 
often the indication for PTA (74% in this study). Of  all 
the variables assessed, only two--short occlusions and 
good runoff--obtained a 2-year patency rate of>50%; 
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the percentages were 57% and 55%, respectively. 
These angiographic variables were mainly in patients 
with claudication whose angioplasty remained patent 
at 2 years. The poor results at 1 and 24 months for 
long occlusions (21% patent) as seen by other au- 
thors, ~3 multiple stenoses (32% patent), poor runoff  
(23% patent), and critical ischemia (39% patent) are 
indicators o f  more severe disease and likely failure. 
Fifty-nine percent ofangioplasties that failed (30% 
of  all PTAs) required asubsequent procedure, most o f  
which were femorodistal grafts (70%). Of  the PTAs 
that failed and had a subsequent procedure, 66% were 
patients with claudication (representing 26% of  all 
patients with claudication). The other 34% had critical 
ischemia (38% of  all patients with critical ischemia). 
O f  the procedures that failed, the subsequent proce- 
dure did not seem to be influenced by the primary 
intervention.~4 
Surprisingly, risk factors did not influence pa- 
tency--especially smoking and diabetes.X s The cumu- 
lative effizct o f  risk factors was not assessed. The overall 
patient survival rate was 91% at 2 years, 96% for 
patients with claudication compared with 76% fbr 
those with critical ischemia, indicating that the former 
had less severe disease. A complication rate o f  25% 
represents a critical evaluation of  all patients and 
possible overreporting of  minor bleeding. A major 
complication rate o f  6% is similar to those of  other 
authors. 6'~6 Ten amputations were perfbrmed within 
2 years (<1%), all in patients with critical ischemia nd 
poor runoff, which is similar to other studies. ~7 
Although PTA is accepted as being minimally 
invasive, it is not without its morbidity. A patency rate 
of  46% at 2 years does not compare favorably with 
stated patency rates o f  femoropopliteal grafts. 18A9 
This discrepancy is further emphasized when consid- 
ering that claudication was the major indication for 
PTA in our study whereas critical ischemia was the 
major indication for bypass surgery. Because failed 
PTA does not adversely effect the outcome of  subse- 
quent procedures, even with its limitations it may be 
a reasonable option--especially for limb salvage in 
patients who have either a shortened life expectancy 
or who are unfit for femorodistal grafting. 2~ 
CONCLUSION 
A 2-year patency rate o f  49% makes recommend- 
ing PTA for claudication difficult, particularly when 
patients who do wctl arc those with either short 
occlusions or good runoff  and who would normally 
do well with conservative management. 
Only patients with short-distance claudication 
should be considered for angiography when the 
treatmcnt is more likcly to bc operative. Thc usc of  
diagnostic arteriography to seek suitable lesions for 
angioplasty is not warranted. 
We thank Sarah Maycock for typing the manuscript, 
Emily Miels for her work in retrieving the angiograms from 
archives, and Kristen Wilson fbr her statistical analysis. 
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